These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Johnson MP; Hoffman AJ; Nichols DE Eur J Pharmacol; 1986 Dec; 132(2-3):269-76. PubMed ID: 2880735 [TBL] [Abstract][Full Text] [Related]
3. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Steele TD; Nichols DE; Yim GK Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126 [TBL] [Abstract][Full Text] [Related]
4. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline. Callahan PM; Appel JB J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488 [TBL] [Abstract][Full Text] [Related]
5. 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. McKenna DJ; Guan XM; Shulgin AT Pharmacol Biochem Behav; 1991 Mar; 38(3):505-12. PubMed ID: 1829838 [TBL] [Abstract][Full Text] [Related]
6. Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices. Fitzgerald JL; Reid JJ Eur J Pharmacol; 1990 Nov; 191(2):217-20. PubMed ID: 1982265 [TBL] [Abstract][Full Text] [Related]
7. A simple organ bath for electrical stimulation and superfusion of rat brain slices. Hoffman AJ; Maxwell DM; Nichols DE J Pharmacol Methods; 1986 Nov; 16(3):185-99. PubMed ID: 3784567 [TBL] [Abstract][Full Text] [Related]
8. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat. Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. Baker LE; Taylor MM Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001 [TBL] [Abstract][Full Text] [Related]
10. Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA). Nichols DE; Brewster WK; Johnson MP; Oberlender R; Riggs RM J Med Chem; 1990 Feb; 33(2):703-10. PubMed ID: 1967651 [TBL] [Abstract][Full Text] [Related]
11. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644 [TBL] [Abstract][Full Text] [Related]
12. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. Johnson MP; Conarty PF; Nichols DE Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125 [TBL] [Abstract][Full Text] [Related]
13. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Yamamoto BK; Spanos LJ Eur J Pharmacol; 1988 Mar; 148(2):195-203. PubMed ID: 2897922 [TBL] [Abstract][Full Text] [Related]
14. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. Feuerstein TJ; Hertting G; Lupp A; Neufang B Br J Pharmacol; 1986 Jul; 88(3):677-84. PubMed ID: 3742155 [TBL] [Abstract][Full Text] [Related]
15. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats. Mokler DJ; Robinson SE; Rosecrans JA Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440 [TBL] [Abstract][Full Text] [Related]
16. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin. Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin. Gazzara RA; Takeda H; Cho AK; Howard SG Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036 [TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons. Evans SM; Johanson CE Drug Alcohol Depend; 1986 Oct; 18(2):159-64. PubMed ID: 2877843 [TBL] [Abstract][Full Text] [Related]
19. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Stone DM; Stahl DC; Hanson GR; Gibb JW Eur J Pharmacol; 1986 Aug; 128(1-2):41-8. PubMed ID: 2875893 [TBL] [Abstract][Full Text] [Related]